Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash and cash equivalents	$ 9,837,001	$ 1,128,389
Equity investments	419,995	200
Notes receivable, net		23,500
Prepaid expenses and other current assets - current	145,324	241,091
Assets of discontinued operations		33,484
Total Current Assets	10,402,320	1,426,664
Note receivable - non-current, including interest receivable of $1,210	61,210
Prepaid expenses - non-current	26,659
Total Assets	10,490,189	1,426,664
CURRENT LIABILITIES:
Accounts payable and accrued expenses	417,937	127,069
Note payable - current portion		14,654
Deferred revenue - current portion	72,102
Total Current Liabilities	490,039	141,723
LONG TERM LIABILITIES:
Deferred revenue - long-term portion	937,884
Note payable - long-term portion		4,246
Total Long Term Liabilities	937,884	4,246
Total Liabilities	1,427,923	145,969
Commitment and Contingencies (see Note 10)
STOCKHOLDERS’ EQUITY:
Preferred stock, value
Common stock, $0.0001 par value, 500,000,000 shares authorized; 98,636,970 and 85,141,956 shares issued and outstanding at December 31, 2021 and 2020, respectively	9,864	8,514
Additional paid-in capital	12,314,979	7,034,502
Accumulated deficit	(3,262,577)	(5,762,321)
Total Stockholders’ Equity	9,062,266	1,280,695
Total Liabilities and Stockholders’ Equity	10,490,189	1,426,664
Series B Convertible Preferred Stock
STOCKHOLDERS’ EQUITY:
Preferred stock, value
Total Stockholders’ Equity
Series C Convertible Preferred Stock
STOCKHOLDERS’ EQUITY:
Preferred stock, value
Total Stockholders’ Equity